참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-Chloromandelic acid | HCID 97720 | — |
| 반응물 | Nilotinib | HCID 644241 | — |
| 용매 | tert-Butyl methyl ether | HCID 15413 | — |
| 생성물 | Nilotinib 2-chloromandelate | HCID 131732356 | — |
반응 단계
Nilotinib base (0.300 g, 0.57 mmol) was dissolved in TFE (2 mL) at 40° C. to obtain a mixture. The mixture was stirred and added to a solution of 2-chloromandelic acid (0.106 g, 0.57 mmol) in TFE (1 mL) at 40° C. Stirring of the resulting clear solution was continued for about 4 h at 40° C. and the solution was subsequently cooled to 5° C. The mixture was kept at 5° C. overnight and then methyl tert-butyl ether (MTBE) (1.5 v/v) was added to the mixture at room temperature, leading to precipitation. The precipitate was filtered to give a white solid of Nilotinib 2-chloromandelate form I.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08937082B2 |
|---|
| 출처 데이터셋 | uspto-grants-2015_01 |
|---|
| ORD ID | ord-373eafd0bb2c429489afb73b8c33dde7 |
|---|
| 출처 메모 | uspto-grants-2015_01 |
|---|